Standard immunocytochemical techniques were used as described
elsewhere.
11 12 Because antigens were not available for
preabsorption controls, we evaluated specificity mainly by comparison
with the results of previous studies using these antibodies and, where
possible, by known homologies between the immunizing proteins and the
primate counterparts.
Working dilutions and sources of antibodies used in this study
included: rabbit anti-calbindin at 1:1000 (Swant
Immunochemicals, Bellinzona, Switzerland), rabbit anti-calretinin at
1:1000 (Swant Immunochemicals), rabbit anti-GABA at 1:1000 and rat
anti-glycine at 1:1000 (both from David V. Pow, University of
Queensland, Australia), mouse anti-NeuN at 1:1000 (Chemicon, Temecula,
CA), mouse anti-Islet-1 at 1:50 (39.4D5; Developmental Studies
Hybridoma Bank, University of Iowa, Iowa City), rabbit anti-Prox1 at
1:1000 (Stanislav Tomarev, National Eye Institute), mouse
anti-neurofilament at 1:100 (RT97; Developmental Studies Hybridoma
Bank), mouse anti-β 3-tubulin at 1:500 (Covance, Princeton, NJ),
mouse anti-rhodopsin at 1:800 (4D2; Robert Molday, University of
British Columbia, Canada), rabbit anti-GCAP2 at 1:2000 (Krzysztof
Palczewski, University of Washington), rabbit anti-cellular
retinaldehyde-binding protein (CRALBP) at 1:5000 (John Saari,
University of Washington, Seattle), and rabbit anti-recoverin at 1:1000
(James Hurley, University of Washington).